Facts and new hopes on selective FGFR inhibitors in solid tumors

Por Facchinetti, Francesco, Hollebecque, Antoine, Bahleda, Rastislav, Loriot, Yohann, Olaussen, Ken A, Massard, Christophe, Friboulet, Luc
Publicado no Clin Cancer Res (2019)

Translational regulation of the mRNA encoding the ubiquitin peptidase USP1 involved in the DNA damage response as a determinant of Cisplatin resistance

Por Sourisseau, Tony, Helissey, Carole, Lefebvre, Céline, Ponsonnailles, Florence, Malka-Mahieu, Hélène, Olaussen, Ken A, André, Fabrice, Vagner, Stephan, Soria, Jean-Charles
Publicado no Cell Cycle (2016)

Synergistic interaction between cisplatin and PARP inhibitors in non-small cell lung cancer

Por Michels, Judith, Vitale, Ilio, Senovilla, Laura, Enot, David P., Garcia, Pauline, Lissa, Delphine, Olaussen, Ken A., Brenner, Catherine, Soria, Jean-Charles, Castedo, Maria, Kroemer, Guido
Publicado em 2013

Inhibition of Chk1 Kills Tetraploid Tumor Cells through a p53-Dependent Pathway

Por Vitale, Ilio, Galluzzi, Lorenzo, Vivet, Sonia, Nanty, Lisa, Dessen, Philippe, Senovilla, Laura, Olaussen, Ken A., Lazar, Vladimir, Prudhomme, Michelle, Golsteyn, Roy M., Castedo, Maria, Kroemer, Guido
Publicado em 2007

TPF induction chemotherapy increases PD-L1 expression in tumour cells and immune cells in head and neck squamous cell carcinoma

Por Leduc, Charlotte, Adam, Julien, Louvet, Emilie, Sourisseau, Tony, Dorvault, Nicolas, Bernard, Marine, Maingot, Elodie, Faivre, Laura, Cassin-Kuo, Mei-Shiue, Boissier, Emilie, Dessoliers, Marie-Charlotte, Robin, Angélique, Casiraghi, Odile, Even, Caroline, Temam, Stéphane, Olaussen, Ken A, Soria, Jean-Charles, Postel-Vinay, Sophie
Publicado no ESMO Open (2018)

Understanding and Overcoming Resistance to Selective FGFR Inhibitors across FGFR2-Driven Malignancies

Por Facchinetti, Francesco, Loriot, Yohann, Brayé, Floriane, Vasseur, Damien, Bahleda, Rastislav, Bigot, Ludovic, Barbé, Rémy, Nobre, Catline, Combarel, David, Michiels, Stefan, Italiano, Antoine, Smolenschi, Cristina, Tselikas, Lambros, Scoazec, Jean-Yves, Ponce-Aix, Santiago, Besse, Benjamin, André, Fabrice, Olaussen, Ken A., Hollebecque, Antoine, Friboulet, Luc
Publicado no Clin Cancer Res (2024)

Tumor Mutation Burden as a Biomarker in Resected Non–Small-Cell Lung Cancer

Por Devarakonda, Siddhartha, Rotolo, Federico, Tsao, Ming-Sound, Lanc, Irena, Brambilla, Elisabeth, Masood, Ashiq, Olaussen, Ken A., Fulton, Robert, Sakashita, Shingo, McLeer-Florin, Anne, Ding, Keyue, Le Teuff, Gwénaël, Shepherd, Frances A., Pignon, Jean-Pierre, Graziano, Stephen L., Kratzke, Robert, Soria, Jean-Charles, Seymour, Lesley, Govindan, Ramaswamy, Michiels, Stefan
Publicado no J Clin Oncol (2018)

DNA repair deficiency sensitizes lung cancer cells to NAD(+) biosynthesis blockade

Por Touat, Mehdi, Sourisseau, Tony, Dorvault, Nicolas, Chabanon, Roman M., Garrido, Marlène, Morel, Daphné, Krastev, Dragomir B., Bigot, Ludovic, Adam, Julien, Frankum, Jessica R., Durand, Sylvère, Pontoizeau, Clement, Souquère, Sylvie, Kuo, Mei-Shiue, Sauvaigo, Sylvie, Mardakheh, Faraz, Sarasin, Alain, Olaussen, Ken A., Friboulet, Luc, Bouillaud, Frédéric, Pierron, Gérard, Ashworth, Alan, Lombès, Anne, Lord, Christopher J., Soria, Jean-Charles, Postel-Vinay, Sophie
Publicado no J Clin Invest (2018)

Feasibility and first reports of the MATCH-R repeated biopsy trial at Gustave Roussy

Por Recondo, Gonzalo, Mahjoubi, Linda, Maillard, Aline, Loriot, Yohann, Bigot, Ludovic, Facchinetti, Francesco, Bahleda, Rastislav, Gazzah, Anas, Hollebecque, Antoine, Mezquita, Laura, Planchard, David, Naltet, Charles, Lavaud, Pernelle, Lacroix, Ludovic, Richon, Catherine, Lovergne, Aurelie Abou, De Baere, Thierry, Tselikas, Lambros, Deas, Olivier, Nicotra, Claudio, Ngo-Camus, Maud, Frias, Rosa L., Solary, Eric, Angevin, Eric, Eggermont, Alexander, Olaussen, Ken A., Vassal, Gilles, Michiels, Stefan, Andre, Fabrice, Scoazec, Jean-Yves, Massard, Christophe, Soria, Jean-Charles, Besse, Benjamin, Friboulet, Luc
Publicado no NPJ Precis Oncol (2020)

Diverse resistance mechanisms to the third-generation ALK inhibitor lorlatinib in ALK-rearranged lung cancer

Por Recondo, Gonzalo, Mezquita, Laura, Facchinetti, Francesco, Planchard, David, Gazzah, Anas, Bigot, Ludovic, Rizvi, Ahsan Z., Frias, Rosa L., Thiery, Jean-Paul, Scoazec, Jean-Yves, Sourisseau, Tony, Howarth, Karen, Deas, Olivier, Samofalova, Dariia, Galissant, Justine, Tesson, Pauline, Braye, Floriane, Naltet, Charles, Lavaud, Pernelle, Mahjoubi, Linda, Abou Lovergne, Aurélie, Vassal, Gilles, Bahleda, Rastislav, Hollebecque, Antoine, Nicotra, Claudio, Ngo-Camus, Maud, Michiels, Stefan, Lacroix, Ludovic, Richon, Catherine, Auger, Nathalie, De Baere, Thierry, Tselikas, Lambros, Solary, Eric, Angevin, Eric, Eggermont, Alexander, André, Fabrice, Massard, Christophe, Olaussen, Ken A., Soria, Jean-Charles, Besse, Benjamin, Friboulet, Luc
Publicado no Clin Cancer Res (2019)